Literature DB >> 9237811

Analysis of human IL-2/IL-2 receptor beta chain interactions: monoclonal antibody H2-8 and new IL-2 mutants define the critical role of alpha helix-A of IL-2.

R Eckenberg1, D Xu, J L Moreau, M Bossus, J C Mazie, A Tartar, X Y Liu, P M Alzari, J Bertoglio, J Theze.   

Abstract

Interleukin 2 (IL-2) interacts with a receptor (IL-2R) composed of three subunits (IL-2R alpha, IL-2R beta and IL-2R gamma). IL-2R beta plays a critical role in signal transduction. An anti-human IL-2 mAb (H2-8) produced after immunization with peptide 1-30 of IL-2 was found to recognize the region occupied by Asp20, at the exposed interface between alpha-helices A and C. Muteins at position 17 and 20 are not recognized by mAb H2-8. mAb H2-8 specifically inhibits the IL-2 proliferation of TS1beta cells which are dependent on the expression of human IL-2R beta chain for IL-2 proliferation. Substitution at internal position Leu17 demonstrates that this position is essential for IL-2 binding and IL-2 bioactivity. New IL-2 mutants at position Asp20 have been analysed. Substitutions Asp --> Asn, Asp --> Lys, Asp --> Leu, show a correlation between diminished affinity for IL-2 receptor and reduced bioactivity measured on TS1beta cells. Mutein Asp Arg lose affinity for IL-2R and bioactivity simultaneously. Furthermore, during the course of the study we have found that mutein Asp20 --> Leu is an IL-2 antagonist. The biological effects of mAb H2-8 and the properties of new mutants at positions 17 and 20 demonstrate that this region of alpha helix-A is involved in IL-2-IL-2R beta interactions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237811     DOI: 10.1006/cyto.1996.0192

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  4 in total

1.  Engineered interleukin-2 antagonists for the inhibition of regulatory T cells.

Authors:  David V Liu; Lisa M Maier; David A Hafler; K Dane Wittrup
Journal:  J Immunother       Date:  2009 Nov-Dec       Impact factor: 4.456

2.  Construction, purification, and characterization of a chimeric TH1 antagonist.

Authors:  Iraldo Bello-Rivero; Yeny Torrez-Ruiz; Elizabeth Blanco-Garcés; Giselle Pentón-Rol; Osmani Fernández-Batista; Luís Javier-González; Haydee Gerónimo-Perez; Pedro López-Saura
Journal:  BMC Biotechnol       Date:  2006-05-22       Impact factor: 2.563

3.  The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells.

Authors:  R Eckenberg; T Rose; J L Moreau; R Weil; F Gesbert; S Dubois; D Tello; M Bossus; H Gras; A Tartar; J Bertoglio; S Chouaïb; M Goldberg; Y Jacques; P M Alzari; J Thèze
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

Review 4.  Structural biology of shared cytokine receptors.

Authors:  Xinquan Wang; Patrick Lupardus; Sherry L Laporte; K Christopher Garcia
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.